Qualigen therapeutics acquires majority stake in infectious disease diagnostics technology company nanosynex

Transaction expected to significantly advance commercial readiness of nano s ynex' s innovative diagnostic s technology platform focused on the $30+ billion global infectious disease testing market

QLGN Ratings Summary

QLGN Quant Ranking